Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06011694

The Jinling Cohort

Sponsor: Nanjing Shihejiyin Technology, Inc.

View on ClinicalTrials.gov

Summary

The Jinling Cohort is a prospective, multicenter cohort study in which 15,000 eligible individuals aged 45-75 in Nanjing China will be enrolled.

Official title: A Prospective, Multicenter Cohort Study of the Multi-omics Liquid Biopsy MCED Test MERCURY in an Average Risk Chinese Population

Key Details

Gender

All

Age Range

45 Years - 75 Years

Study Type

OBSERVATIONAL

Enrollment

15000

Start Date

2022-06-15

Completion Date

2027-05-15

Last Updated

2023-08-25

Healthy Volunteers

Yes

Interventions

OTHER

MERCURY test, health questionnaires and annual routine physical exams

Each participant will undergo peripheral blood collection for MERCURY test, health questionnaires and annual routine physical exams once a year for three consecutive years, then followed up two additional years.

Locations (2)

Nanjing Jiangbei People's Hospital

Nanjing, Jiangsu, China

The Fourth Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China